Ocugen (OCGN) Operating Income Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 32.96% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -29.67% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -50.81% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 13.47% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 16.35% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -12.10% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 55.96% |
| 10 | Ocugen | 452.01 Mn | 452.01 Mn | - | 0.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.36% |
| Dec 31, 2025 | 10.05% |
| Sep 30, 2025 | 11.13% |
| Jun 30, 2025 | 13.85% |
| Mar 31, 2025 | 8.66% |
| Dec 31, 2024 | 1.70% |
| Sep 30, 2024 | -7.09% |
| Jun 30, 2024 | 15.51% |
| Mar 31, 2024 | -20.07% |
| Dec 31, 2023 | -44.65% |
| Sep 30, 2023 | -6.88% |
| Jun 30, 2023 | -91.23% |
| Mar 31, 2023 | -66.19% |
| Dec 31, 2022 | -76.06% |
| Sep 30, 2022 | -109.94% |
| Jun 30, 2022 | -110.04% |
| Mar 31, 2022 | -57.82% |
| Dec 31, 2021 | -36.82% |
| Sep 30, 2021 | -64.94% |
| Jun 30, 2021 | -52.06% |
| Mar 31, 2021 | -5.02% |
| Dec 31, 2020 | 14.22% |
| Sep 30, 2020 | -21.24% |
| Jun 30, 2020 | 19.17% |
| Mar 31, 2020 | 16.83% |
| Dec 31, 2019 | 18.50% |
| Sep 30, 2019 | 25.82% |
| Jun 30, 2019 | 33.60% |
| Mar 31, 2019 | 14.69% |
| Dec 31, 2018 | 11.88% |
| Sep 30, 2018 | 33.12% |
| Jun 30, 2018 | 1.38% |
| Mar 31, 2018 | 8.19% |
| Dec 31, 2017 | 2.65% |
| Sep 30, 2017 | 27.42% |
| Jun 30, 2017 | -1.98% |
| Mar 31, 2017 | -9.70% |